Cargando…

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

Antibodies directed to the Sa antigen are highly specific for rheumatoid arthritis (RA) and can be detected in approximately 40% of RA sera. The antigen, a doublet of protein bands of about 50 kDa, is present in placenta and in RA synovial tissue. Although it has been stated that the Sa antigen is c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vossenaar, Erik R, Després, Normand, Lapointe, Elvy, van der Heijden, Annemarie, Lora, Maximillian, Senshu, Tatsuo, van Venrooij, Walther J, Ménard, Henri A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400433/ https://www.ncbi.nlm.nih.gov/pubmed/15059278 http://dx.doi.org/10.1186/ar1149

Ejemplares similares

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin
por: Vossenaar, ER, et al.
Publicado: (2004)

Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis
por: Vossenaar, Erik R, et al.
Publicado: (2004)

Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis
por: Vossenaar, Erik R, et al.
Publicado: (2004)

Citrullination of synovial proteins in murine models of rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Insights into rheumatoid arthritis derived from the Sa immune system
por: Ménard, Henri A, et al.
Publicado: (2000)

How citrullination invaded rheumatoid arthritis research
por: van Venrooij, Walther J, et al.
Publicado: (2014)

Citrullinated Peptides as a Substrate for the Detection of Rheumatoid Arthritis-Specific Autoantibodies
por: van Venrooij, Walther J
Publicado: (2000)

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
por: Pruijn, Ger JM, et al.
Publicado: (2010)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
por: Van Steendam, Katleen, et al.
Publicado: (2011)

Citrullination: a small change for a protein with great consequences for rheumatoid arthritis
por: van Venrooij, Walther J, et al.
Publicado: (2000)

Citrullinated proteins in arthritis: presence in joints and effects on immunogenicity
por: Lundberg, K, et al.
Publicado: (2004)

Expression of PAD enzymes and occurrence of citrulline-containing proteins in human blood and synovial fluid cells
por: Vossenaar, ER, et al.
Publicado: (2002)

Features of the citrullinating peptidylarginine deiminase enzymes
por: Vossenaar, ER, et al.
Publicado: (2004)

Expression of citrullin-containing antigens in RA synovium
por: Smeets, TJ, et al.
Publicado: (2001)

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value
por: van Boekel, Martinus AM, et al.
Publicado: (2002)

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
por: Van Steendam, Katleen, et al.
Publicado: (2010)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
por: Dejaco, Christian, et al.
Publicado: (2006)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
por: Safi, Mohammad-Ayman A., et al.
Publicado: (2015)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
por: Avdeeva, A. S., et al.
Publicado: (2014)

Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity
por: Lundberg, Karin, et al.
Publicado: (2005)

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis
por: Berglin, Ewa, et al.
Publicado: (2004)

Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis
por: de França, Natalia Regine, et al.
Publicado: (2022)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
por: Mansour, Howaida E., et al.
Publicado: (2010)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
por: Ursum, Jennie, et al.
Publicado: (2008)

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis
por: Gilliam, Brooke E, et al.
Publicado: (2013)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
por: Lindenberg, Luisa, et al.
Publicado: (2015)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
por: Norouzi, Somayye, et al.
Publicado: (2020)

An important step towards completing the rheumatoid arthritis cycle
por: van Venrooij, Walther J, et al.
Publicado: (2008)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

Multiplex autoantibody profiling using 'synovial proteome' microarrays identifies citrulline-modified peptides as major targets of the autoimmune response in rheumatoid arthritis
por: Hueber, W, et al.
Publicado: (2003)

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis
por: Boire, Gilles, et al.
Publicado: (2005)

Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
por: van Venrooij, Walther J., et al.
Publicado: (2007)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
por: Díaz-Toscano, Miriam Lizette, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n0fela7qsd9jhfbk6e876tedaa